Financhill
Back

Xeris Biopharma Holdings Stock Predictions

Xeris Biopharma Holdings Stock Forecast

  • Is Xeris Biopharma Holdings Stock Undervalued?
    The current Xeris Biopharma Holdings [XERS] share price is $3.09. The Score for XERS is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
  • XERS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.

Will Xeris Biopharma Holdings Stock Go Up Next Year?

Data Unavailable

Xeris Biopharma Holdings Stock Rating

Data Unavailable

Xeris Biopharma Holdings Stock Price History

Is XERS stock going to rise?

  • The current trend is relatively stagnant and XERS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
xerispharma.com

52-Week Data

52-Week High:
3.64
52-Week Low:
1.69

Prediction Charts

Market Cap:
460.66M
Price in USD:
3.09
Volume:
734.79K
Beta:
1.46

Technical Analysis

SMA50:
3.03
SMA100:
2.78
SMA200:
2.51
52-Wk Change:
77.59%

Stock Predictions

  • Is Xeris Biopharma Holdings stock public?
    Yes, Xeris Biopharma Holdings is a publicly traded company.
  • What is the Xeris Biopharma Holdings stock quote today?
    The Xeris Biopharma Holdings stock price is 3.09 USD today.
  • How to buy Xeris Biopharma Holdings stock online?
    You can buy Xeris Biopharma Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 3.25 3.26 3.28 3.10
Nov-6 3.31 3.34 3.39 3.25
Nov-7 3.34 3.36 3.42 3.28
Nov-8 3.40 3.47 3.64 3.06
Nov-11 3.43 3.28 3.43 3.21
Nov-12 3.25 3.16 3.27 3.03
Nov-13 3.20 3.15 3.33 3.15
Nov-14 3.15 3.05 3.16 3.04
Nov-15 3.07 2.92 3.07 2.91
Nov-18 2.91 2.90 2.93 2.82
Nov-19 2.86 3.01 3.01 2.86
Nov-20 2.99 3.06 3.08 2.96
Nov-21 3.08 3.04 3.12 3.03
Nov-22 3.04 3.09 3.10 3.02

Xeris Biopharma Holdings Earnings

Data Unavailable

Xeris Biopharma Holdings Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.06 per share.

* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.